BioVaxys Technology Corp. BVAXF

Primary Symbol: C.BIOV

BioVaxys Technology Corp. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on improving patient lives with novel immunotherapies based on the DPX immune-educating technology platform and its HapTenix neoantigen tumor cell construct platform, for treating cancers, infectious disease, antigen desensitization and other immunological fields. The Company's clinical-stage pipeline includes maveropepimut-S, which is in phase II clinical development for advanced Relapsed-Refractory Diffuse Large B Cell Lymphoma (DLBCL) and platinum resistant ovarian cancer, and BVX-0918, a personalized immunotherapeutic vaccine using its HapTenix neoantigen tumor cell construct platform for treating refractive late-stage ovarian cancer. The Company is also leveraging its expertise in tumor immunology by creating a unique library of T-lymphocytes and other datasets post-vaccination with its personalized immunotherapeutic vaccines to identify new targetable tumor antigens.

CSE:BIOV - Post by User

BioVaxys Technology Corp.

<< Previous

Bullboard Posts

Next >>

Post by moneywagonon Oct 05, 2022 3:39pm

122 Views

Post# 35007576

BIOV OVER I MILLION TRADES~DID YA GET SOME? POWER HOUR PLEAS

C:BIOV - BioVaxys Technology Corp. - https://biovaxys.com

15:37:45 EDT

Sym-X	Bid - Ask					Last	Chg	%Ch	Vol	$Vol	#Tr	Open-Hi-Lo	Year Hi-Lo	Last Tr	News	Delay
BIOV - C	7.5	0.17	·	0.175	10.0	0.17	+0.065	61.9	982.8	125	252	0.12 0.17 0.115	0.465 0.085	15:14:42	Sep 29	15 min RT 2¢
CSE - C	7.5	0.17	·	0.175	10.0	0.17	+0.065	61.9	648.2	84	138	0.12 0.17 0.115	0.465 0.085	15:14:42		15 min
NEO ATS - U						0.165	+0.06	57.1	246.0	30	67	0.125 0.165 0.12		15:11:25		15 min
Omega - O						0.165	+0.06	57.1	40.0	5	15	0.13 0.165 0.12		15:03:15		15 min
Chi-X - X						0.12	+0.015	14.3	5.0	1	1	0.12 0.12 0.12		11:48:41		15 min
CX2 - H						0.16	+0.055	52.4	40.6	5	15	0.125 0.16 0.12		14:17:29		15 min
TriAct - M						0.105			3.0		16					15 min